The objective of this study was to determine the effects of cis-9,trans-11 and trans-10,cis-12 CLA on the fatty acid desaturation in a human hepatoma cell line, HepG2. Therefore, experiments were conducted in which HepG2 cells were incubated with various concentrations of those fatty acids and the concentrations of fatty acids in various lipid fractions of HepG2 cells were determined. In the presence of linoleic acid as substrate, cells treated with 25 micromol/L of trans-10,cis-12 CLA had lower ratios of dihomo-gamma-linoleic acid to linoleic acid and of arachidonic acid to linoleic acid in phospholipids than control cells; with alpha-linolenic acid as substrate, they had a lower ratio of eicosapentaenoic acid to alpha-linolenic acid in phospholipids than control cells. Cells treated with cis-9,trans-11 CLA did not differ in these ratios from control cells. Cells treated with trans-10,cis-12 CLA had also a markedly lower ratio of monounsaturated fatty acids (MUFA) to saturated fatty acids (SFA) in lipids than control cells; cells treated with cis-9,trans-11 CLA had a slightly lower MUFA:SFA ratio than control cells. These findings suggest that trans-10,cis-12 CLA suppresses Delta9-, Delta6- and Delta5-desaturation in HepG2 cells; cis-9,trans-11 CLA slightly reduces Delta9-desaturation but does not inhibit Delta6- and Delta5-desaturation. Moreover, HepG2 cells treated with 100 micromol/L of trans-10,cis-12 CLA released larger amounts of 6-keto-prostaglandin F(1alpha) and prostaglandin F(2alpha) than control cells. Treatment of cells with cis-9,trans-11 CLA did not alter the release of these eicosanoids compared with control cells. In conclusion, this study suggests that trans-10,cis-12 CLA has significant effects on the metabolism of essential fatty acids in HepG2 cells, whereas cis-9, trans-11 CLA does not have any effect in this respect.

This study investigated the metabolism of alpha-linolenic acid and the formation of eicosanoids in rats fed diets with three different dietary fats (30 g/kg diet): either a conjugated linoleic acid (CLA) preparation with a high concentration of cis-9, trans-11 CLA (32.2 g/100 g) and trans-10, cis-12 CLA (33.3 g/100 g) and a low concentration of linoleic acid (0.5 g/100 g), sunflower oil (SFO) with a high concentration of linoleic acid or high-oleic acid sunflower oil (HO-SFO) with a high concentration of oleic acid. Basal diets with those oils were fed for 4 weeks. In the fifth week, the same diets supplemented with 50 g of linseed oil/kg as a source of alpha-linolenic acid were fed. To study the effect of the oils on the metabolism of alpha-linolenic acid, the amounts of individual (n-3) polyunsaturated fatty acids (PUFA) in liver phospholipids (phosphatidyl choline and phosphatidyl ethanolamine) were determined; to study the effect on eicosanoid formation, the concentrations of various two-series eicosanoids in liver and plasma, the activity of the secretory phospholipase A2 and the relative mRNA concentrations of cyclooxygenases-1 and 2 in the liver were measured. Rats fed the CLA diets had the highest concentrations of long chain (n-3) PUFA deriving from delta6, delta5 and 14-desaturation of alpha-linolenic acid in liver phospholipids; rats fed the SFO diet had the lowest concentrations of those fatty acids. The concentration of arachidonic acid in liver phospholipids and the concentrations of eicosanoids in liver and plasma were lowest in rats fed the CLA diet and highest in the rats fed the SFO diet. Moreover, rats fed the CLA diet had a higher gene expression of delta6-desaturase in the liver than the other two groups of rats. The results show that feeding the CLA oil reduced the formation of arachidonic acid and eicosanoids but enhanced the formation of long chain (n-3) PUFA and their incorporation into tissue lipids when compared with feeding SFO or HO-SFO.

The objective of this study was to determine the effects of cis-9, trans-11 and trans-10, cis-12 CLA on the delta4-desaturation process in HepG2 cells. Experiments were conducted in which HepG2 cells were incubated with 25 micromol/L of those fatty acids and the concentrations of (n-6) and (n-3) polyunsaturated fatty acids in phosphatidyl choline and phosphatidyl ethanolamine were determined. In the presence of eicosapentaenoic acid, cells treated with trans-10, cis-12 CLA had a lower ratio of docosahexaenoic acid [22:6 (n-3)], the product of delta4-desaturation, to docosapentaenoic acid [22:5 (n-3)], the substrate of delta4-desaturation in both phospholipids, than control cells or cells treated with cis-9, trans-11 CLA (p < 0.05). This suggests that trans-10, cis-12 CLA suppresses the delta4-desaturation process in HepG2 cells.

No abstract